Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON31583
NL-OMON31583
Completed
Phase 4

A pilot study on the effect of apomorphine on visual perception in patients with Parkinson's disease and visual hallucinations - Apomorphine and visual hallucinations in Parkinson's disease

niversitair Medisch Centrum Groningen0 sites10 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionshypokinetic rigid syndromeParkinson's disease10028037

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
hypokinetic rigid syndrome
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
10
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Diagnosed Parkinson\*s Disease according to the UK Brain Bank Criteria
  • •2\. Al least weekly hallucinations during the past month
  • •3\. MMSE \>24
  • •4\. FAB\>\=12
  • •5\. Patient must be able to understand the procedure
  • •6\. Medication must be stable for at least a month

Exclusion Criteria

  • •1\. Visual problems (cataract, macula degeneration, severe retinal patholgy, visus\<.5\)
  • •2\. Patients with cerebral electrodes for deep brain stimulation
  • •3\. Presence of other neurological or psychiatric affections
  • •4\. Unstable internal disease
  • •5\. Patients who already use apomorphine

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Effet de l'apomorphine sur la perception douloureuse chez le patient parkinsonien : étude clinique et en tomographie par émission de positons.maladie de ParkinsonMedDRA version: 8.1Level: LLTClassification code 10013113Term: Disease Parkinson's
EUCTR2006-005318-11-FRCHU Toulouse
Suspended
Phase 2
Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain InjuryBrain Injury
NCT00761228NeuroHealing Pharmaceuticals Inc.76
Completed
Phase 2
Continued Efficacy of Apomorphine After Previous Exposure of at Least Three MonthsParkinson Disease
NCT00200512Mylan Bertek Pharmaceuticals16
Recruiting
Phase 3
Effect of morphin in prognose of Anterior MIAcute Anterior ST Elevatiom Myocardial Infarction.ST elevation (STEMI) myocardial infarction of anterior wallI21.0
IRCT20230102057018N1Research Assistant of Tabriz University of Medical Sciences200
Completed
Phase 4
The Effects of Apomorphine on Experimental and Clinical Pain in Patients With Chronic Radicular PainChronic Low Back Pain
NCT02969629Rambam Health Care Campus59